answer text |
<p>In the period in question, the major National Institute for Health Research (NIHR)
funding for biomedical research was through its Biomedical Research Centres and Units.
These support research funded by the NIHR itself and also research funded by other
public, charity and industry research funders. The level of funding for biomedical
research into chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for each
financial year can be found in the table below. The funding for this research came
from a combination of funders.</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>280,442</p></td></tr><tr><td><p>2015-16</p></td><td><p>295,626</p></td></tr><tr><td><p>2016-17</p></td><td><p>130,958</p></td></tr></tbody></table><p>
</p><p>The NIHR Clinical Research Network (CRN) provides the infrastructure that allows
high-quality clinical research funded by charities, research funders and life-sciences
industry to be undertaken throughout the National Health Service. The level of funding
for biomedical research into CFS/ME for each financial year can be found in the table
below. The funding for this research came from a combination of the NIHR, the Medical
Research Council (MRC) and medical research charities. Expenditure from the CRN coordinating
centre itself is also outlined below:</p><p> </p><table><tbody><tr><td><p>Financial
Year</p></td><td><p>CRN funding for research, £</p></td><td><p>Coordinating expenditure,
£</p></td></tr><tr><td><p>2014-15</p></td><td><p>134,769</p></td><td><p>17,485</p></td></tr><tr><td><p>2015-16</p></td><td><p>125,176</p></td><td><p>17,796</p></td></tr><tr><td><p>2016-17</p></td><td><p>82,866</p></td><td><p>7,821</p></td></tr></tbody></table><p>
</p><p>The MRC spend on research directly relating to CFS/ME can be found in the following
table. Research into CFS/ME is a continuing priority for the MRC.</p><p> </p><table><tbody><tr><td><p>Financial
Year</p></td><td><p>£</p></td></tr><tr><td><p>2014-15</p></td><td><p>652,044</p></td></tr><tr><td><p>2015-16</p></td><td><p>287,234</p></td></tr><tr><td><p>2016-17</p></td><td><p>286,197</p></td></tr></tbody></table><p>
</p><p>The NIHR and the MRC welcomes funding applications for research into any aspect
of human health, including biomedical research into CFS/ME. It is not usual practice
to ring-fence funds for particular topics or conditions. Applications are subject
to peer review and judged in open competition, with awards being made on the basis
of the importance of the topic to patients and health and care services, value for
money and scientific quality. On this basis, it is not possible to say how much funding
is planned in the current financial year.</p><p> </p><p>The NIHR recognises that CFS/ME
is a debilitating condition and is speaking with the United Kingdom CFS/ME Research
Collaborative and patient representatives about how best we can support a joined up
approach to high quality research into this complex disorder.</p>
|
|